MRC1 and breast cancer: We identified mUNO from an in vivo screen using a peptide library in mice bearing metastatic breast cancer; we subsequently described how mUNO homed to CD206+ TAMs in other solid tumor models (41, 78) and in early-stage models of TNBC (42) displaying low hepatic accumulation.